mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BIBW2992 |
FIMM |
pan-cancer |
AAC |
-0.049 |
0.8 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |